Skip to main content

Day: September 5, 2024

Repeat: Treatment.com AI and University of Edinburgh Join Forces to Transform Long-Term Care Services across the UK

Collaboration with World Leading University, University of Edinburgh Multi-Million Dollar Transformative Project for Long-Term Care Future Partnering OpportunitiesVANCOUVER, British Columbia, Sept. 05, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with the University Court of the University of Edinburgh (“University of Edinburgh”). The University of Edinburgh is looking to utilize Treatment’s proprietary Global Library of Medicine (“GLM”) to jointly build applications within the “SET4 Systems Engineering to Transform Transitions In Health and Social Care innovation initiative” (“SET4”). World Leading University Treatment is partnering with the University of Edinburgh, recently acknowledged as amongst the world’s...

Continue reading

Lantheus Appoints Julie Eastland as New Board Member

BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced the appointment of Julie Eastland, an experienced biotechnology and financial executive, to Lantheus’ Board of Directors (“Board”), effective as of September 3, 2024. As an independent director, Ms. Eastland will serve as a member of the Board’s Audit Committee. Following the appointment of Ms. Eastland, the Board will be comprised of ten directors, eight of whom are independent. “We are thrilled to welcome Julie Eastland to the Lantheus Board of Directors. Ms. Eastland’s extensive biotechnology expertise across finance, strategic planning, operations and transactions...

Continue reading

Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its progress toward completion of the clinical study plan required for its FDA 510(k) submission. In August 2024, INBS announced its partnership with CenExel to perform the method comparison study as part of the Company’s clinical study plan. The study involves the recruitment of 135 healthy adult subjects across three sites under an IRB-approved protocol and comparing the results of fingerprint sweat opiate screening tests with those obtained using a validated, traceable liquid chromatography-mass spectrometry (LC-MS/MS) method in a laboratory. The Company has successfully completed...

Continue reading

Enerpac Tool Group Announces Acquisition of DTA

MILWAUKEE, Sept. 05, 2024 (GLOBE NEWSWIRE) — Enerpac Tool Group Corp. (NYSE: EPAC) (“Enerpac” or the “Company”) announced today that it completed the acquisition of Madrid, Spain-based DTA The Smart Move, S.A. (“DTA”), a global leader in the industrial heavy loads transportation industry, designing and manufacturing mobile robotic solutions. The purchase price is €24 million plus potential for a three-year earn-out tied to the achievement of certain financial objectives. The purchase price will be funded with a combination of cash on hand and borrowings from the Company’s credit facility. The acquisition of DTA advances Enerpac Tool Group’s pure-play industrial tools and solutions strategy by adding automated on-site horizontal movement products to its Heavy Lifting Technology (HLT) portfolio and capitalizes on the trend towards...

Continue reading

Seafood Market to Gain USD 564.98 Billion by 2031 | SkyQuest Technology

Westford, USA, Sept. 05, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Global Seafood Market will attain a value of USD 564.98 Billion by 2031, with a CAGR of 6.52% during the forecast period (2024-2031). Growth in this industry is expected to be significantly influenced by the development of travel and hospitality sectors. This is because they help promote and serve seafood dishes to tourists and travellers. Seafood is usually a conspicuous part on menus in restaurants, hotels, resorts, cruise ships and other venues because of the demand for fish products coming from travellers seeking for unique culinary adventure. Download a detailed overview: https://www.skyquestt.com/sample-request/seafood-market Browse in-depth TOC on the ” Seafood Market “Pages – 165 Tables – 100 Figures – 77Seafood Market Overview:Report...

Continue reading

Admission to trading of AB Šiaulių bankas Notes on Euronext Dublin

THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER, INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF AKCINĖ BENDROVĖ ŠIAULIŲ BANKAS. On 5 September 2024 the EUR 300,000,000 4.853 per cent. Fixed Rate Reset Callable Senior Preferred Notes of AB Šiaulių bankas were successfully admitted to the official list of Euronext Dublin and to trading on the regulated market of Euronext Dublin administered by the Irish Stock Exchange plc. This communication is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of securities or possession or distribution of this announcement in any jurisdiction...

Continue reading

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering

CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the pricing of a public offering of 14,724,058 shares of common stock, par value $0.001 per share (each a “Share,” and collectively, the “Shares”) at a public offering price of $0.13 per Share and pre-funded warrants to purchase up to 11,972,754 Shares at a price of $0.129 per pre-funded warrant with an exercise price of $0.001 per share (the “Pre-Funded Warrants”). The Pre-Funded Warrants are exercisable upon issuance and will remain exercisable until exercised in full. The closing of the offering is expected to occur on or about September 6, 2024, subject to the satisfaction of customary closing conditions. Univest Securities, LLC acted as the exclusive placement agent for the offering. The gross proceeds...

Continue reading

Kartoon Channel to Launch “Kidaverse Roblox Rumble” Competition Series This Fall

Series taps the popular Roblox game, which is played by over 30 million every day Third season to launch globally on Kartoon Channel in 60 territories, including North America, Asia, Europe, Africa, and The Middle East Winners receive prizes that include iPhones, iPads, custom Nike shoes, and a PlayStation 5BEVERLY HILLS, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) — Kartoon Studios (NYSE American: TOON) today announced it will launch a Roblox-based competition series for kids, which will premiere this Fall on the company’s rapidly growing streaming service Kartoon Channel. Tapping into the game’s massive audience played by over 30 million every day, the third season of Kidaverse Roblox Rumble will have a global premiere in over 60 territories, including North America, Asia, Europe, and The Middle East. Created by Kartoon...

Continue reading

Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment

Meeting showcases the potential role of Nexalin’s neurostimulation technology in revolutionizing opioid treatment through virtual care solutions HOUSTON, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announced its participation in a high-profile Congressional roundtable in North Carolina, focused on emerging virtual therapeutic options for opioid treatment. The event was hosted by the Breaking Barriers for Substance Use Recovery initiative and featured key stakeholders from across the healthcare and policy spectrum. The roundtable, held with Dr. Greg Murphy, U.S. Congressman representing North Carolina’s 3rd District, centered on the deployment of virtual-based opioid therapy models across the country. Dr. Murphy, Congress’ only actively practicing physician,...

Continue reading

Non-Destructive Testing (NDT) Market to Exceed USD 32.48 billion by 2031 | SkyQuest

Westford, USA, Sept. 05, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Global Non-Destructive Testing (NDT) Market will attain a value of USD 32.48 billion by 2031, with a CAGR of 7.60% over the forecast period (2024-2031). Non-destructive testing services are used by industries such as oil and gas, automotive, and power that include research and development practices, which involve training and business-focused logistics. The method is normally applied in checking for corrosion both inside and outside of oil and gas pipelines within the gas and oil industry. There are four kinds of inspections that are utilized during the process of visual, liquid penetrant, magnetic particle, and ultrasonic. To examine steam and gas turbines, as well as pressure systems, the power sector uses NDT. Download a detailed overview: https://www.skyquestt.com/sample-request/non-destructive-testing-market...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.